Close Lucintel Chat
Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • Call Lucintel +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in Thyroid Cancer Diagnostic Market Report. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


Thyroid Cancer Diagnostic Trends and Forecast
The future of the global thyroid cancer diagnostic market looks promising with opportunities in the hospital, associated lab, independent diagnostic laboratory, diagnostic imaging center, and cancer research institute markets. The global thyroid cancer diagnostic market is expected to reach an estimated $7.6 billion by 2030 with a CAGR of 5.5% from 2024 to 2030. The major drivers for this market are the increasing incidence of thyroid cancer, growing focus on real time diagnosis and treatment, and rising awareness towards thyroid cancer.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Thyroid Cancer Diagnostic by Segment
The study includes a forecast for the global thyroid cancer diagnostic by product type, test type, end use, and region.

Thyroid Cancer Diagnostic Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:
• Instruments
• Consumables & Accessories









Thyroid Cancer Diagnostic Market by Test Type [Shipment Analysis by Value from 2018 to 2030]:
• Imaging Test
• Biopsy
• Blood Test
• Others







Thyroid Cancer Diagnostic Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
• Hospital
• Associated Labs
• Independent Diagnostic Laboratories
• Diagnostic Imaging Centers
• Cancer Research Institutes
• Others

















Thyroid Cancer Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Thyroid Cancer Diagnostic Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies thyroid cancer diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the thyroid cancer diagnostic companies profiled in this report include-
• Abbott
• Hoffmann-La Roche
• Thermo Fisher Scientific
• Siemens Healthcare
• Bio-Rad Laboratories
• General Electric
• Koninklijke Philips
• Toshiba Corporation
• Agilent Technologies
• Illumina


Thyroid Cancer Diagnostic Market Insights
Lucintel forecasts that imaging test will remain the largest segment due to the increasing demand of high resolution and real time image testing.
Within this market, hospitals will remain the largest segmnt over the forecast period due to growing inflow of cancer diagnosis patient in hospitals, increasing consumer awareness, and growing investments in healthcare infrastructure across the globe.
North America will remain the largest region due to increasing prevalence of thyroid cancer, rising healthcare expenditure, and favourable government initiative in the US for awareness, diagnostic and treatment.

Features of the Global Thyroid Cancer Diagnostic Market

Market Size Estimates: Thyroid cancer diagnostic market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Thyroid cancer diagnostic market size by product type, test type, end use, and region in terms of value ($B).
Regional Analysis: Thyroid cancer diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different product types, test types, end uses, and regions for the thyroid cancer diagnostic market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the thyroid cancer diagnostic market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q.1 What is the thyroid cancer diagnostic market size?
Answer: The global thyroid cancer diagnostic market is expected to reach an estimated $7.6 billion by 2030.

Q.2 What is the growth forecast for thyroid cancer diagnostic market?
Answer: The global thyroid cancer diagnostic market is expected to grow with a CAGR of 5.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the thyroid cancer diagnostic market?
Answer: The major drivers for this market are the increasing incidence of thyroid cancer, growing focus on real time diagnosis and treatment, and rising awareness towards thyroid cancer.

Q4. What are the major segments for thyroid cancer diagnostic market?
Answer: The future of the thyroid cancer diagnostic market looks promising with opportunities in the hospital, associated lab, independent diagnostic laboratory, diagnostic imaging center, and cancer research institute markets.

Q5. Who are the key thyroid cancer diagnostic market companies?
Answer: Some of the key thyroid cancer diagnostic companies are as follows:
• Abbott
• Hoffmann-La Roche
• Thermo Fisher Scientific
• Siemens Healthcare
• Bio-Rad Laboratories
• General Electric
• Koninklijke Philips
• Toshiba Corporation
• Agilent Technologies
• Illumina



Q6. Which thyroid cancer diagnostic market segment will be the largest in future?
Answer: Lucintel forecasts that imaging test will remain the largest segment due to the increasing demand of high resolution and real time image testing.

Q7. In thyroid cancer diagnostic market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region due to increasing prevalence of thyroid cancer, rising healthcare expenditure, and favourable government initiative in the US for awareness, diagnostic and treatment.

Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the thyroid cancer diagnostic market by product type (instruments and consumables & accessories), test type (imaging test, biopsy, blood test, and others), end use (hospital, associated labs, independent diagnostic laboratories, diagnostic imaging centers, cancer research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

For any questions related to Thyroid Cancer Diagnostic Market, Thyroid Cancer Diagnostic Market Size, Thyroid Cancer Diagnostic Market Growth, Thyroid Cancer Diagnostic Market Analysis, Thyroid Cancer Diagnostic Market Report, Thyroid Cancer Diagnostic Market Share, Thyroid Cancer Diagnostic Market Trends, Thyroid Cancer Diagnostic Market Forecast, Thyroid Cancer Diagnostic Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents

1. Executive Summary

2. Global Thyroid Cancer Diagnostic Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 

3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Thyroid Cancer Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Thyroid Cancer Diagnostic Market by Product Type
3.3.1: Instruments
3.3.2: Consumables & Accessories








3.4: Global Thyroid Cancer Diagnostic Market by Test Type
3.4.1: Imaging Test
3.4.2: Biopsy
3.4.3: Blood Test
3.4.4: Others






3.5: Global Thyroid Cancer Diagnostic Market by End Use
3.5.1: Hospital
3.5.2: Associated Labs
3.5.3: Independent Diagnostic Laboratories
3.5.4: Diagnostic Imaging Centers
3.5.5: Cancer Research Institutes
3.5.6: Others














4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Thyroid Cancer Diagnostic Market by Region
4.2: North American Thyroid Cancer Diagnostic Market
4.2.1: North American Thyroid Cancer Diagnostic Market by Test Type: Imaging Test, Biopsy, Blood Test, and Others
4.2.2: North American Thyroid Cancer Diagnostic Market by End Use: Hospital, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, and Others


4.3: European Thyroid Cancer Diagnostic Market

4.3.1: European Thyroid Cancer Diagnostic Market by Test Type: Imaging Test, Biopsy, Blood Test, and Others
4.3.2: European Thyroid Cancer Diagnostic Market by End Use: Hospital, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, and Others


4.4: APAC Thyroid Cancer Diagnostic Market

4.4.1: APAC Thyroid Cancer Diagnostic Market by Test Type: Imaging Test, Biopsy, Blood Test, and Others
4.4.2: APAC Thyroid Cancer Diagnostic Market by End Use: Hospital, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, and Others


4.5: ROW Thyroid Cancer Diagnostic Market

4.5.1: ROW Thyroid Cancer Diagnostic Market by Test Type: Imaging Test, Biopsy, Blood Test, and Others
4.5.2: ROW Thyroid Cancer Diagnostic Market by End Use: Hospital, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, and Others


5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis

6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Thyroid Cancer Diagnostic Market by Product Type
6.1.2: Growth Opportunities for the Global Thyroid Cancer Diagnostic Market by Test Type
6.1.3: Growth Opportunities for the Global Thyroid Cancer Diagnostic Market by End Use

6.1.4: Growth Opportunities for the Global Thyroid Cancer Diagnostic Market by Region

6.2: Emerging Trends in the Global Thyroid Cancer Diagnostic Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Thyroid Cancer Diagnostic Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Thyroid Cancer Diagnostic Market
6.3.4: Certification and Licensing

7. Company Profiles of Leading Players
7.1: Abbott
7.2: Hoffmann-La Roche
7.3: Thermo Fisher Scientific
7.4: Siemens Healthcare
7.5: Bio-Rad Laboratories
7.6: General Electric
7.7: Koninklijke Philips
7.8: Toshiba Corporation
7.9: Agilent Technologies
7.10: Illumina
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Thyroid Cancer Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030 Full Report $ 4,850
150 - page report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.

Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.

Please sign in below to get report brochure - Thyroid Cancer Diagnostic Market Report.

At Lucintel, we respect your privacy and maintain the confidentiality of information / data provided by you
(Please enter your corporate email. * These fields are mandatory )